PHBI — Pharmagreen Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- $0.86m
- $1.17m
- $0.00m
Annual cashflow statement for Pharmagreen Biotech, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.44 | -4.53 | -0.876 | -0.569 | -1 |
| Non-Cash Items | 1.94 | 4.42 | 0.206 | 0.143 | 0.725 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.108 | -0.09 | 0.243 | 0.352 | 0.251 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.608 | -0.206 | -0.427 | -0.074 | -0.028 |
| Capital Expenditures | 0 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | — | — | — | — |
| Financing Cash Flow Items | -0.03 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.563 | 0.258 | 0.314 | 0.083 | 0.029 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.05 | 0.013 | -0.017 | -0.007 | -0.001 |